SCHEMBL6820873

SCHEMBL6820873

Cc1cc(Cl)ccc1C(=S)c1ccc(Nc2ccc(Br)cc2NC(=O)CCC(=O)O)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
POLB P06746 3/20 0.46
LMNA P02545 1/20 0.46
MAPK13 O15264 2/20 0.43
MAPK12 P53778 2/20 0.43
MAPK11 Q15759 2/20 0.43
MAPK14 Q16539 2/20 0.43
KDM4E B2RXH2 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
EGFR P00533 1/20 0.39
ERBB3 P21860 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
BLM P54132 1/20 0.38
ALDH1A1 P00352 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6820715 0.92 MAPK1 (0.46) MAPK1SMN1; SMN2POLBLMNAMAPK13
SCHEMBL6821228 0.91 MAPK1 (0.46) MAPK1SMN1; SMN2POLBLMNAMAPK13
SCHEMBL6817261 0.91 MAPK1 (0.54) MAPK1SMN1; SMN2POLBLMNAMAPK13
SCHEMBL6817260 0.91 MAPK1 (0.54) MAPK1SMN1; SMN2POLBLMNAMAPK13
SCHEMBL6820950 0.88 MAPK1 (0.45) MAPK1SMN1; SMN2POLBLMNAMAPK13
SCHEMBL6820955 0.88 MAPK1 (0.45) MAPK1SMN1; SMN2POLBLMNAMAPK13
SCHEMBL6817328 0.88 MAPT (0.44) MAPK1SMN1; SMN2POLBLMNAMAPK13
SCHEMBL6817758 0.88 MAPK1 (0.48) MAPK1SMN1; SMN2MAPK13MAPK12MAPK11
SCHEMBL6817754 0.88 MAPK1 (0.48) MAPK1SMN1; SMN2MAPK13MAPK12MAPK11
SCHEMBL6816770 0.87 MAPK1 (0.41) MAPK1SMN1; SMN2POLBLMNAMAPK13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1210320-B1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMA AS (DK) 2004-09-29 EP claimed
US-6566554-B1 Including amino benzothiophenones; useful for treatment of inflammatory diseases in which the production of cytokines is involved in the pathogenesis LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 2003-05-20 US claimed
EP-1210320-B1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMA AS (DK) 2004-09-29 EP disclosed
US-6566554-B1 Including amino benzothiophenones; useful for treatment of inflammatory diseases in which the production of cytokines is involved in the pathogenesis LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 2003-05-20 US disclosed